PT-002

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePT-002

Drug Alias NamePT-002PT 002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionInterleukin-2 replacements

TargetsInterleukin-2 receptor

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPandion Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesPandion Therapeutics

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A